THE present study objectively evaluated the efficacy of oral 5 mg day(
-1) melatonin in advancing the sleep-wake rhythm in patients with dela
yed sleep phase syndrome (DSPS). Six patients underwent ambulatory sle
ep monitoring for 72 h before and 48 h after 1 month of melatonin trea
tment. In each patient melatonin was administered on the basis of his
own estimated dim light melatonin onset (DLMO) delay. Mean advances in
sleep onset time of 115 min and in final awakening hour of 106 min we
re found after treatment, with no significant changes in sleep archite
cture parameters. Our study objectively confirms previous data obtaine
d by a sleep-wake subjective diary on the efficacy of melatonin DSPS.